Skip to main content
Shanghai Medicilon Inc. logo

Shanghai Medicilon Inc. — Investor Relations & Filings

Ticker · 688202 ISIN · CNE100003NQ8 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 817 across all filing types
Latest filing 2020-04-15 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688202

About Shanghai Medicilon Inc.

https://www.medicilon.com.cn/

Shanghai Medicilon Inc. is a comprehensive contract research organization providing integrated drug discovery and development services to the global pharmaceutical and biotechnology sectors. The company offers a full spectrum of preclinical services, including medicinal chemistry, lead optimization, in vitro and in vivo biology, pharmacology, and drug metabolism and pharmacokinetics (DMPK). Medicilon specializes in safety evaluation and toxicology studies conducted in GLP-compliant facilities to support Investigational New Drug (IND) applications. Its integrated platform facilitates the transition of drug candidates from initial discovery through preclinical development, covering both small molecule drugs and biologics. By leveraging advanced technology and scientific expertise, the company assists clients in accelerating drug development timelines and optimizing research outcomes.

Recent filings

Filing Released Lang Actions
关于聘任公司2020年度审计机构及内控审计机构的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the appointment of the company's audit firm for the 2020 fiscal year. It details the proposed audit firm, its qualifications, personnel, independence, and the approval process including board and shareholder meeting approvals. It does not contain any actual audit report, financial statements, or audit results. The document is relatively short (2656 characters) and serves as a formal announcement of the appointment rather than the audit report itself. Therefore, it fits best under the category of Audit Report / Information (AR) since it relates specifically to audit matters but is not a full annual report or audit report document. However, given the document is an announcement of the appointment of the audit firm rather than the audit report or audit results, it is more appropriate to classify it as Regulatory Filings (RNS) because it is a regulatory announcement about audit firm appointment and related procedures, not the audit report itself.
2020-04-15 Chinese
关于向银行申请授信额度的公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement from Shanghai Medicilon Inc. regarding the company's board approval to apply for a bank credit facility up to 200 million RMB. It details the types of credit facilities sought and the authorization for management to sign related legal documents. There is no financial report, earnings data, or detailed financial statements. The document is an update on financing activities, specifically about credit/loan arrangements. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or certification. Hence, the classification is CAP with high confidence.
2020-04-15 Chinese
2019年年度报告
Annual Report Classification · 100% confidence The document is titled '2019 年年度报告' which translates to '2019 Annual Report'. It is issued by Shanghai Medicilon Inc. and contains detailed sections typical of an annual report, including company overview, financial data, risk factors, business summary, governance, and audited financial statements. The document length is substantial (15,000 characters) and includes comprehensive financial and operational information for the fiscal year 2019. It also mentions the audit report with an unqualified opinion, which is usually part of an annual report. There is no indication that this is merely an announcement or a summary; rather, it is the full annual report itself. Therefore, the appropriate classification is Annual Report (10-K). FY 2019
2020-04-15 Chinese
立信会计师事务所（特殊普通合伙）关于对公司控股股东及其他关联方占用资金情况的专项审计说明
Regulatory Filings
2020-04-15 Chinese
第二届监事会第八次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of resolutions passed at the Supervisory Board meeting of Shanghai Medicilon Inc. It includes approvals of various reports and proposals such as the 2019 Supervisory Board Work Report, 2019 Financial Statements, 2019 Profit Distribution Plan, 2019 Annual Report, and other related matters. However, the document itself is not the full annual report or financial statements but rather a meeting resolution announcement summarizing approvals and indicating that the full reports are published separately on the Shanghai Stock Exchange website. The document length is 2643 characters, which is relatively short and consistent with an announcement rather than a full report. The document does not contain the full financial data or detailed report content but references them as published elsewhere. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a formal regulatory announcement of meeting resolutions and approvals, not the actual annual report or financial statements.
2020-04-15 Chinese
2019年年度利润分配预案公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the company's 2019 annual profit distribution plan. It details the decision not to distribute dividends or convert capital reserves into shares, citing reasons related to asset acquisition plans and company bylaws. The document includes board and supervisory committee approvals and mentions that the plan will be submitted to the shareholders' meeting for approval. The document length is 2611 characters, which is relatively short and primarily serves as a formal announcement of the profit distribution plan rather than a full financial report or annual report. It does not contain comprehensive financial statements or detailed financial analysis. Therefore, it fits best as a Notice of Dividend Amount (DIV) announcement, as it informs shareholders about the dividend decision and related details.
2020-04-15 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.